Materialise Launches the Materialise Mimics Care Suite, the Platform for 3D Printing in Hospitals
March 01 2016 - 7:00AM
Business Wire
The Materialise Mimics Care Suite aims to
accelerate and improve the integration of certified medical 3D
printing within hospitals
Materialise NV (NASDAQ:MTLS), is proud to announce the launch
of the Materialise Mimics Care Suite, a full suite of software and
solutions for 3D printing within hospitals. The Materialise Mimics
Care Suite is an open and flexible platform that includes planning
and design software tools, 3D printed anatomical models and
surgical guides, and patient-specific implants. Launched during
AAOS, the American Association of Orthopaedic Surgeon’s Annual
Meeting, the Suite also introduces Materialise Mimics inPrint, a
new software solution that enables surgeons to create accurate
medical models for 3D printing in hospitals without the need of
advanced clinical engineering support.
With the Materialise Mimics Care Suite, Materialise brings
together medical software and services, both established and new,
into a single, neutral platform that facilitates the further
integration of 3D planning and printing into hospitals. For
example, Materialise Mimics inPrint allows clinicians to 3D print
in hospitals by connecting data from all modern imaging systems to
the ever expanding range of 3D printers on the market. The
Materialise Mimics Care Suite also includes software for predictive
planning and communication; patient-specific guides that transfer a
co-created surgical plan to the OR; and patient-specific models and
implants that enable surgeons to treat complex cases.
Materialise Founder and CEO, Wilfried Vancraen, states, “For
more than 25 years, we at Materialise have been identifying
meaningful applications of 3D printing and developing the backbone
of software and solutions needed to successfully bring them to
market. We see incredible potential for 3D printing in hospitals,
but have also recognized that many existing solutions have slowed
adoption of the technology. Therefore, we have developed the
Materialise Mimics Care Suite with the aim of helping hospitals
better integrate 3D printing and begin unleashing the benefits it
offers, which include potential cost savings and patient care
improvement.”
Since their foundation, Materialise has been providing
leading-edge, 3D visualization and printing solutions to their
extensive list of hospital, academic and medical device customers.
Materialise’s open and flexible platform of software and services
forms the foundation of certified medical 3D Printing, in clinical
as well as research environments, enabling medical professionals to
revolutionize patient treatment and make the world a better and
healthier place.
About MaterialiseMaterialise incorporates more than 25
years of 3D printing experience into a range of software solutions
and 3D printing services, which together form the backbone of the
3D printing industry. Materialise’s open and flexible solutions
enable players in a wide variety of industries, including
healthcare, automotive, aerospace, art and design, and consumer
goods, to build innovative 3D printing applications that aim to
make the world a better and healthier place. Headquartered in
Belgium, with branches worldwide, Materialise combines the largest
group of software developers in the industry with one of the
largest 3D printing facilities in the world. For additional
information, please visit: www.materialise.com.
About Materialise’s Medical DivisionMaterialise Medical,
which has pioneered many of the leading medical applications of 3D
printing, enables researchers, engineers and clinicians to
revolutionize innovative patient-specific treatment that helps
improve and save lives. Materialise Medical’s open and flexible
platform of software and services, Materialise Mimics, form the
foundation of certified Medical 3D Printing, in clinical as well as
research environments, offering virtual planning software tools,
3D-printed anatomical models, and patient-specific surgical guides
and implants. For additional information, please visit:
http://hospital.materialise.com/
Cautionary Statement on Forward-Looking StatementsSome of
the statements in this press release are "forward-looking" and are
made pursuant to the safe harbor provision of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements include statements relating to, among other things, our
planned commercialization efforts and regulatory approvals of our
technologies as well as the success thereof and our research and
development projects. These forward-looking statements are based
upon the expectations of management under current assumptions at
the time of this press release. We caution you that forward-looking
statements are not guarantees of future performance and involve
known and unknown risks, uncertainties and other factors that are
in some cases beyond our control that may cause our actual results
to differ materially from our expectations. We are providing this
information as of the date of this press release and do not
undertake any obligation to update any forward-looking statements
contained in this presentation as a result of new information,
future events or otherwise, unless we have obligations under the
federal securities laws to update and disclose material
developments related to previously disclosed information.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160301005928/en/
Press contacts:Vanessa PalsenbargCorporate Communications
Manager, MaterialisePhone: +32-16-39-66-37Fax:
+32-16-39-66-00Email: press@materialise.comTwitter: @belgiancanuck
or @MaterialiseNVVisit: www.materialise.com
Materialise NV (NASDAQ:MTLS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Materialise NV (NASDAQ:MTLS)
Historical Stock Chart
From Sep 2023 to Sep 2024